Search results
Octapharma USA Appoints New VP of Commercial Marketing & Development
New Jersey Business Magazine· 2 days agoOctapharma USA, Inc. has appointed pharmaceutical industry veteran Kelly Hearn as vice president of...
Earnings call: Longeveron reports Q1 2024 results, optimistic on Lomecel-B
Investing.com· 5 days agoLongeveron Inc. (LGVN), a leader in regenerative medicine, recently discussed its first-quarter...
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for...
CBS 47 Fresno· 7 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the ...
Ionis reports positive results for Angelman syndrome drug By Investing.com
Investing.com· 6 days agoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) today shared encouraging topline results from the HALOS...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoPreliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell
Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell...
WFRV 5 Green Bay· 6 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Pharma company raises millions to fund Alzheimer's, cardiovascular drug research - South Florida...
The Business Journals· 6 days agoLongeveron raised millions in equity investments after reporting it was close to running out of cash. The pharmaceutical firm announced it received $11.4 million in capital investments from ...
EveryLife Foundation Announces Scientific Workshop on 'Ultra-Rare' Diseases
KTLA-TV Los Angeles· 6 days agoWhile significant strides have been made with legislative tools like the Orphan Drug Act, only a small fraction of rare diseases have FDA-approved treatments ...
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From...
WPRI Providence· 2 days agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, will present new biomarker data suggesting that ALS patients ...
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance
WROC Rochester· 1 day agoKS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A ...